Product Description
Haltrust 440 Injection is a hot-selling, peerless option for HER2-positive breast and gastric cancer treatment. Featuring the impeccable Trastuzumab lyophilized powder, this value-packed antineoplastic injection is administered intravenously after dissolving the white to off-white cake or powder in supplied sterile water. Strictly prescription-based, Haltrust 440 is WHO-GMP certified and marketed by Halcyon Labs Pvt. Ltd., India, ensuring glorious quality standards. Each 440 mg vial offers outstanding efficacy, but shop now and follow your oncologist's precise dosage and physician instructions for safe and effective use.
Haltrust 440 Injection: Targeted Cancer Therapy
Specifically indicated for HER2-positive breast and gastric cancer, Haltrust 440 Injection is suitable for adults requiring advanced biologic treatment. Its impeccable composition of Trastuzumab ensures potent action against malignant cells. Recommended usage involves intravenous infusion under a specialist's supervision, following strict dosage instructions provided by an oncologist. This peerless therapy should only be considered on a prescription basis, after a thorough assessment of the patient's medical history. Patient health details must be shared with the physician prior to initiation for optimized safety.
Packaging & Certification: Assured Value for Your Expenditure
Haltrust 440 Injection comes thoughtfully packaged with one vial (440 mg lyophilized powder) and an ampoule of sterilized water for reconstitution. Each box is WHO-GMP certified to guarantee high standards and safety. With an estimated life span of 24 months from manufacture, the sample availability depends on service provider or trading policies. The sale price reflects the advanced biotechnology and quality assurance. Proper refrigeration (2C-8C) is essential to preserve its efficacy, ensuring that every purchase delivers exceptional value for your expenditure.
FAQ's of Haltrust 440 Injection:
Q: How should Haltrust 440 Injection be administered?
A: Haltrust 440 Injection is administered through intravenous infusion. The lyophilized powder must be dissolved in the supplied sterile water before it is given to the patient, strictly following the physician's infusion protocol.
Q: What is the main benefit of using Haltrust 440 Injection?
A: The chief benefit of Haltrust 440 Injection lies in its targeted action against HER2-positive breast and gastric cancers, offering peerless efficacy as a monoclonal antibody biological therapy under medical supervision.
Q: When is Haltrust 440 Injection recommended for use?
A: This injection is recommended by oncologists for adult patients diagnosed with HER2-positive breast cancer or gastric cancer. The precise timing and dosage are determined by the patient's condition and the oncologist's guidelines.
Q: Where should Haltrust 440 Injection be stored?
A: It should be refrigerated between 2C and 8C. Do not freeze the product, and ensure it is kept away from direct sunlight or heat to maintain its efficacy for the duration of its 24-month life span.
Q: What precautions should patients take when using Haltrust 440 Injection?
A: Patients must inform their physician about all medications and health conditions prior to starting treatment. Patients with pre-existing heart conditions should use this injection cautiously. All unused medicine should be disposed of as per bio-medical waste protocols.